A New Approach to Inspection Readiness for Life Science Companies
A New Approach to Inspection Readiness for Life Science Companies
November 19, 2025
In the life sciences world, compliance is not just a requirement. It is an ongoing responsibility that shapes how companies should operate day in, day out. Whether it’s producing pharmaceuticals, medical devices, or supporting regulated manufacturing, staying ready for an FDA, or any global regulatory body, inspection means keeping up with rules that change faster than ever.
On May 6th 2025 the FDA announced they would be conducting unannounced foreign inspections of firms. FDA Announcement of Unannounced Foreign Inspection.
Additionally there is increased supply chain scrutiny, including national defense related initiatives in the United States such as the 2025 NDAA including BioSecure. A New Precedence: National Defense Authorization Act for Fiscal Year 2026
Global Key Solutions (GKS) was created to make this easier. As regulatory expectations grow exponentially more complex, Quality and Regulatory teams need clear information, reliable data, and tools that help them stay ahead. GKS’s Regulatory Intelligence Platform (KeyPedia) gives organizations that foundation, so inspection readiness becomes a normal part of daily operations, not a rushed project once a year.